Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1997 Jun;24(3 Suppl 9):S9-81-S9-93.

Induction of interleukin-1 and interleukin-1 receptor antagonist

C A Dinarello  1
Affiliations
  • PMID: 9208877
Review

Induction of interleukin-1 and interleukin-1 receptor antagonist

C A Dinarello. Semin Oncol. 1997 Jun.

Abstract

Drugs that affect the production or action, or both, of the pleiotropic inflammatory cytokine interleukin-1 (IL-1) are predicted to have a significant impact on a variety of human diseases. The biochemical properties of IL-1 and the IL-1 receptor antagonist, the mechanism for their production, and the factors that regulate their release are discussed here. The association of IL-1 with various disease states is also reviewed. Various classes of drugs that can be used to manipulate the production of IL-1 and IL- I receptor antagonist are described. Interferon-alpha2b is a potent inhibitor in vitro of the induction of IL-1 and tumor necrosis factor by IL-1 and can induce high circulating levels of the anti-inflammatory soluble tumor necrosis factor receptor and IL-1 receptor antagonist in humans. Thus, interferon-alpha2b exhibits potent anti-inflammatory effects.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources